EcoDrugPlus

Adrm1 26s Proteasome Ubiquitin Receptor

Ensembl ID : ENSCGOG00000022439
Gene Symbol: ADRM1
3 Cross references
193 Possible Orthologues:

Atp Binding Cassette Subfamily C Member 8

Ensembl ID : ENSCGOG00000004820
Gene Symbol: ABCC8
3 Cross references
227 Possible Orthologues:

Atp Binding Cassette Subfamily C Member 9

Ensembl ID : ENSCGOG00000008457
Gene Symbol: ABCC9
3 Cross references
233 Possible Orthologues:

Atpase H+/k+ Transporting Subunit Alpha

Ensembl ID : ENSCGOG00000013438
Gene Symbol: ATP4A
3 Cross references
183 Possible Orthologues:

Atpase H+/k+ Transporting Subunit Beta

Ensembl ID : ENSCGOG00000018616
Gene Symbol: ATP4B
3 Cross references
171 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 1

Ensembl ID : ENSCGOG00000000207
Gene Symbol: ATP1B1
3 Cross references
216 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 2

Ensembl ID : ENSCGOG00000016554
Gene Symbol: ATP1B2
3 Cross references
193 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 3

Ensembl ID : ENSCGOG00000011509
Gene Symbol: ATP1B3
3 Cross references
229 Possible Orthologues:

Atr Serine/threonine Kinase

Ensembl ID : ENSCGOG00000024025
Gene Symbol: ATR
3 Cross references
205 Possible Orthologues:

Axl Receptor Tyrosine Kinase

Ensembl ID : ENSCGOG00000014768
Gene Symbol: AXL
3 Cross references
188 Possible Orthologues:

B-Raf Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSCGOG00000003426
Gene Symbol: BRAF
3 Cross references
220 Possible Orthologues:

B1 Bradykinin Receptor-Like

Ensembl ID : ENSCGOG00000006377
Gene Symbol: LOC115027669
3 Cross references
149 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).